A randomized trial to evaluate the pharmacokinetics, pharmacodynamics, and safety of vadadustat in patients with anemia associated with chronic kidney disease receiving hemodialysis.
Saved in:
| Title: | A randomized trial to evaluate the pharmacokinetics, pharmacodynamics, and safety of vadadustat in patients with anemia associated with chronic kidney disease receiving hemodialysis. |
|---|---|
| Authors: | Navarro-Gonzales P; Akebia Therapeutics, Inc, 245 1st St, Cambridge, MA, 02142, USA., Chavan A; Akebia Therapeutics, Inc, 245 1st St, Cambridge, MA, 02142, USA., Wang D; Akebia Therapeutics, Inc, 245 1st St, Cambridge, MA, 02142, USA., Burke SK; Akebia Therapeutics, Inc, 245 1st St, Cambridge, MA, 02142, USA., Dykstra K; Akebia Therapeutics, Inc, 245 1st St, Cambridge, MA, 02142, USA. kdykstra@Akebia.com. |
| Source: | BMC nephrology [BMC Nephrol] 2025 Aug 11; Vol. 26 (1), pp. 453. Date of Electronic Publication: 2025 Aug 11. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100967793 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2369 (Electronic) Linking ISSN: 14712369 NLM ISO Abbreviation: BMC Nephrol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
